Search Count: 16
 |
Pad2 With An Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2025-07-30 Classification: HYDROLASE Ligands: A1CE0, CA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-07-30
Ligands: A1CE0, CA
 |
Potent Inhibition Of The Protein Arginine Deiminases (Pad1-4) By Targeting A Ca2+ Dependent Allosteric Binding Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: CA, A1A8O |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-28
Ligands: CA, A1A8O
 |
Inhibiting Peptidylarginine Deiminases (Pad1-4) By Targeting A Ca2+ Dependent Allosteric Binding Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2025-05-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CA, A1BZK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-28
Ligands: CA, A1BZK
 |
Potent Inhibition Of The Protein Arginine Deiminases (Pad1-4) By Targeting A Ca2+ Dependent Allosteric Binding Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2025-05-28 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1A9P, 3YZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-05-28
Ligands: A1A9P, 3YZ
 |
Vanin-1 Complexed With Compound 3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2022-01-12 Classification: HYDROLASE Ligands: NAG, 9TC, NA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-01-12
Ligands: NAG, 9TC, NA
 |
Vanin-1 Complexed With Compound 11
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-01-12 Classification: HYDROLASE Ligands: NAG, 9SS, NA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-01-12
Ligands: NAG, 9SS, NA
 |
Vanin-1 Complexed With Compound 27
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2022-01-12 Classification: HYDROLASE Ligands: NAG, 9S5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-01-12
Ligands: NAG, 9S5
 |
Crystal Structure Of Ask1 Kinase Domain With A Potent Inhibitor (Analog 6)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2018-01-17 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 9E1, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-01-17
Ligands: 9E1, DMS
 |
Crystal Structure Of Ask1 Kinase Domain With A Potent Inhibitor (Analog 13)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.84 Å Release Date: 2018-01-17 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 9E4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-01-17
Ligands: 9E4
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GZ
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GY
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GX |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GX
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GV
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GT
 |
Design And Synthesis Of A Pan-Jak Kinase Inhibitor Clinical Candidate (Pf-06263276) Suitable For Inhaled And Topical Delivery For The Treatment Of Inflammatory Diseases Of The Lungs And Skin
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2017-01-11 Classification: Transferase/Transferase Inhibitor Ligands: 7GS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-11
Ligands: 7GS
 |
Potent And Selective Isophthalamide S2 Hydroxyethylamine Inhibitor Of Bace1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2007-06-19 Classification: HYDROLASE Ligands: PO4, MR0 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2007-06-19
Ligands: PO4, MR0